276 related articles for article (PubMed ID: 22684816)
1. Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion.
Elsammak MY; Attia A; Hassan HA; Zaytoun TM; Shorman M; Suleman M
Tumour Biol; 2012 Oct; 33(5):1701-7. PubMed ID: 22684816
[TBL] [Abstract][Full Text] [Related]
2. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of human epididymis protein 4 in malignant pleural effusion in lung cancer.
Lv M; Wang F; Wang X; Zhang C
Cancer Biomark; 2019; 26(4):523-528. PubMed ID: 31658049
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pro-inflammatory cytokine and pro-angiogenesis factor in differentiating malignant from benign exudative effusion.
Elhefny RA; Shaban MM; Shaker OG
Clin Respir J; 2017 Jan; 11(1):49-57. PubMed ID: 25832725
[TBL] [Abstract][Full Text] [Related]
5. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
Korczynski P; Krenke R; Safianowska A; Gorska K; Abou Chaz MB; Maskey-Warzechowska M; Kondracka A; Nasilowski J; Chazan R
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
Bayram N; Karakan Y; Uyar M; Ozyurt B; Filiz A
Niger J Clin Pract; 2018 Jan; 21(1):59-62. PubMed ID: 29411725
[TBL] [Abstract][Full Text] [Related]
8. Transudative malignant pleural effusions: prevalence and mechanisms.
Ashchi M; Golish J; Eng P; O'Donovan P
South Med J; 1998 Jan; 91(1):23-6. PubMed ID: 9438397
[TBL] [Abstract][Full Text] [Related]
9. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion.
Wang C; Peng J; Kuang Y; Zhang J; Dai L
Mol Med Rep; 2017 Aug; 16(2):1147-1156. PubMed ID: 28627685
[TBL] [Abstract][Full Text] [Related]
11. Pleural Fluid Serum Bilirubin Ratio for Differentiating Exudative and Transudative Effusions.
Agrawal P; Shrestha TM; Prasad PN; Aacharya RP; Gupta P
JNMA J Nepal Med Assoc; 2018; 56(211):662-665. PubMed ID: 30381760
[TBL] [Abstract][Full Text] [Related]
12. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
13. Useful tests on the pleural fluid in the management of patients with pleural effusions.
Light RW
Curr Opin Pulm Med; 1999 Jul; 5(4):245-9. PubMed ID: 10407695
[TBL] [Abstract][Full Text] [Related]
14. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
15. Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion.
Villena V; Echave-Sustaeta J; Lopez-Encuentra A; Martin-Escribano P; Estenoz-Alfaro J; Ortuño-de-Solo B
Int J Biol Markers; 1995; 10(3):161-5. PubMed ID: 8551059
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of pleural fluid cytologic examination].
Zablockis R; Nargela R
Medicina (Kaunas); 2002; 38(12):1171-8. PubMed ID: 12552157
[TBL] [Abstract][Full Text] [Related]
17. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
18. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
19. Pleural fluid amino-terminal brain natriuretic peptide in patients with pleural effusions.
Cincin A; Abul Y; Ozben B; Tanrikulu A; Topaloglu N; Ozgul G; Karakurt S; Oktay A
Respir Care; 2013 Feb; 58(2):313-9. PubMed ID: 22710710
[TBL] [Abstract][Full Text] [Related]
20. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
Zennaro L; Vanzani P; Nicolè L; Cappellesso R; Fassina A
Cancer Cytopathol; 2017 May; 125(5):341-348. PubMed ID: 28140518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
